FDA 101 for Surgical Oncologists: Intro to FDA and the Center for Biologics Evaluation and Research (CBER) (2022 Webinar)

Activity Overview

Join SSO for a free webinar two part series featuring faculty from the FDA. Learn about the Food and Drug Administration (FDA) and its role in surgical oncology as it relates to biologics. Find out what FDA regulates, what an approval means, and key regulatory approaches. Learn about the Center for Biologics Evaluation and Research (CBER) and regulatory perspectives on cell and gene based cancer therapies. Participants will be provided with information on resources available from FDA.

Faculty
Adnan Jaigirdar, MD, FDA CBER
Gautam Mehta, MD, FDA CDER
Genevieve Boland, MD, PhD, SSO
Darren Carpizo, MD, PhD, SSO

Part two of the series will take place on Thursday, September 8 at Thursday, 5 PM ET, with a focus on the Food and Drug Administration (FDA) and its role in surgical oncology as it relates to drugs. Participants will learn about investigational new drug applications (INDs) and the Oncology Center of Excellence (OCE).

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered